Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene augmentation in schizophrenia spectrum disorder
NL-OMON27943Not yet recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in schizophrenia, schizophreniform disorder, schizoaffective disorder and 1 more comparing Raloxifene augmentation with Placebo augmentation (2 arms). Primary endpoints: Change in symptom severity and Change in cognition. Planned start Apr 2016; status: not yet recruiting.
02
Drugs
raloxifene
03
Conditions
schizophreniaschizophreniform disorderschizoaffective disorderUnspecified psychosis
Beyond the preview
Go deeper on NL-OMON27943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27943.